3rd Quarter - Report

FEROX STRATEGIES for VIATRIS INC

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.